The medtech, which notably markets a digital microscope, has been owned by private equity fund Cambria since 2016. Established in the United States and Italy, the company has chosen an IPO on Euronext Growth, a market suited to its ambitions, according to it. The size of the deal is rather modest as we are talking about a fundraising...